1. Home
  2. XNCR vs ULH Comparison

XNCR vs ULH Comparison

Compare XNCR & ULH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • ULH
  • Stock Information
  • Founded
  • XNCR 1997
  • ULH 1932
  • Country
  • XNCR United States
  • ULH United States
  • Employees
  • XNCR N/A
  • ULH N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • ULH Trucking Freight/Courier Services
  • Sector
  • XNCR Health Care
  • ULH Industrials
  • Exchange
  • XNCR Nasdaq
  • ULH Nasdaq
  • Market Cap
  • XNCR 547.8M
  • ULH 618.7M
  • IPO Year
  • XNCR 2013
  • ULH 2005
  • Fundamental
  • Price
  • XNCR $11.79
  • ULH $21.70
  • Analyst Decision
  • XNCR Buy
  • ULH Hold
  • Analyst Count
  • XNCR 11
  • ULH 1
  • Target Price
  • XNCR $22.20
  • ULH $29.00
  • AVG Volume (30 Days)
  • XNCR 1.2M
  • ULH 31.6K
  • Earning Date
  • XNCR 11-05-2025
  • ULH 10-23-2025
  • Dividend Yield
  • XNCR N/A
  • ULH 1.95%
  • EPS Growth
  • XNCR N/A
  • ULH N/A
  • EPS
  • XNCR N/A
  • ULH 2.31
  • Revenue
  • XNCR $146,929,000.00
  • ULH $1,668,148,000.00
  • Revenue This Year
  • XNCR $23.31
  • ULH N/A
  • Revenue Next Year
  • XNCR N/A
  • ULH $5.57
  • P/E Ratio
  • XNCR N/A
  • ULH $9.33
  • Revenue Growth
  • XNCR N/A
  • ULH N/A
  • 52 Week Low
  • XNCR $6.92
  • ULH $20.60
  • 52 Week High
  • XNCR $27.24
  • ULH $53.29
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 80.95
  • ULH 34.28
  • Support Level
  • XNCR $10.24
  • ULH $23.10
  • Resistance Level
  • XNCR $10.66
  • ULH $24.02
  • Average True Range (ATR)
  • XNCR 0.61
  • ULH 1.08
  • MACD
  • XNCR 0.14
  • ULH -0.27
  • Stochastic Oscillator
  • XNCR 79.71
  • ULH 20.99

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About ULH Universal Logistics Holdings Inc.

Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.

Share on Social Networks: